Comparative Study of Three NNRTI-Sparing HAART Regimens
Condition: HIV InfectionInterventions: Drug: Emtricitabine/tenofovir disoproxil fumarate; Drug: Raltegravir; Drug: Darunavir; Drug: Ritonavir; Drug: AtazanavirSponsors: AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Bristol-Myers Squibb; Gilead Sciences; Merck Sharp & Dohme Corp.; Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompleted - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Biotechnology | Highly Active Antiretroviral Therapy | Infectious Diseases | Isentress | Norvir | Prezista | Research | Study